@wombat777
This makes sense. Also as I understand, the purpose of a US-based phase 2/3 trial is for regulatory/FDA approval, as much as it is about collecting more data on efficacy.
I believe the concern over IND really has to do with shareholders' expectation of a transaction. The buyout objective was pushed from ~1 year to ~2/3 years as a result of cardio-protection discovery. Further delays could make some of the shareholders unhappy (regardless of increasing RAC's buyout value).
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing invitation
Ann: Race investor briefing invitation, page-17
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M |
Open | High | Low | Value | Volume |
$1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.56 | 1400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.525 |
1 | 828 | 1.505 |
1 | 6664 | 1.500 |
2 | 4000 | 1.490 |
1 | 38500 | 1.480 |
Price($) | Vol. | No. |
---|---|---|
1.555 | 1400 | 1 |
1.560 | 2500 | 1 |
1.640 | 1000 | 1 |
1.650 | 14314 | 2 |
1.690 | 585 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |